ALung Technologies

About:

ALung Technologies develops medical gas exchange devices for the treatment of acute and chronic respiratory disorders.

Website: http://www.alung.com

Twitter/X: ALungTech

Top Investors: Smithfield Trust, Allos Ventures, Philips Healthcare, Abiomed, UPMC

Description:

ALung Technologies is a medical device manufacturing company that develops intracorporeal and extracorporeal gas exchange devices for the treatment of acute and chronic respiratory disorders. Its technology utilizes Hemolung, an extracorporeal gas exchange device that circulates blood through a small catheter; and Hattler Catheter, which is placed within the central venous bloodstream in the primary vein that returns blood to the heart and is inserted directly through the skin into the vein. The company was founded in 1997 and headquartered in Pittsburgh, Pennsylvania.

Total Funding Amount:

$113M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Pittsburgh, Pennsylvania, United States

Founded Date:

1997-01-01

Contact Email:

info(AT)alung.com

Founders:

Brack Hattler, Nick Kuhn, William Federspiel

Number of Employees:

501-1000

Last Funding Date:

2020-11-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai